Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Polycythemia vera: myths, mechanisms, and management.

× No keyword cloud information.

94 in total

1. Diagnosis and Management of Polycythemia Vera: Proceedings from a Multidisciplinary Roundtable.

Authors: Lisa A Raedler
Journal: Am Health Drug Benefits Date: 2014-10

2. Jakafi (Ruxolitinib): First FDA-Approved Medication for the Treatment of Patients with Polycythemia Vera.

Authors: Lisa A Raedler
Journal: Am Health Drug Benefits Date: 2015-03

3. JAK2(V617F): Prevalence in a large Chinese hospital population.

Authors: Xuesong Xu; Qi Zhang; Jian Luo; Shu Xing; Qingshan Li; Sanford B Krantz; Xueqi Fu; Zhizhuang Joe Zhao
Journal: Blood Date: 2006-08-31 Impact factor: 22.113

Review 4. Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond.

Authors: Alfonso Quintás-Cardama; Hagop Kantarjian; Jorge Cortes; Srdan Verstovsek
Journal: Nat Rev Drug Discov Date: 2011-02 Impact factor: 84.694

5. Peripheral retinal neovascularization associated with polycythemia rubra vera.

Authors: Radhika Krishnan
Journal: Jpn J Ophthalmol Date: 2009-03-31 Impact factor: 2.447

Review 6. Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms.

Authors: Somedeb Ball; Kyaw Zin Thein; Abhishek Maiti; Kenneth Nugent
Journal: J Thromb Thrombolysis Date: 2018-05 Impact factor: 2.300

7. Polycythemia is associated with bone loss and reduced osteoblast activity in mice.

Authors: P R Oikonomidou; C Casu; Z Yang; B Crielaard; J H Shim; S Rivella; M G Vogiatzi
Journal: Osteoporos Int Date: 2015-12-09 Impact factor: 4.507

8. Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway.

Authors: Wei Zhao; Claire Kitidis; Mark D Fleming; Harvey F Lodish; Saghi Ghaffari
Journal: Blood Date: 2005-10-04 Impact factor: 22.113

9. Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cells.

Authors: Min Lu; Xiaoli Wang; Yan Li; Joseph Tripodi; Goar Mosoyan; John Mascarenhas; Marina Kremyanskaya; Vesna Najfeld; Ronald Hoffman
Journal: Blood Date: 2012-08-07 Impact factor: 22.113

10. An unknown cause of aortic valve stenosis: polycythemia vera.

Authors: Giovanni Fazio; Clementina Caracciolo; Rita Barone; Luciana D'angelo; Rosario Di Maggio; Federica Vernuccio; Sergio Siragusa
Journal: J Thromb Thrombolysis Date: 2013-02 Impact factor: 2.300